Table 1.
Case | Age | Gender | Symptoms to death | Immediate COD | Condition leading to COD | Underlying cause | Comorbidities/conditions |
---|---|---|---|---|---|---|---|
1 | 26 years | Male | 181 days | Mesenteric ischemia | SARS-CoV-2 pneumonia | – | Coinfection with CMV/HHV-1 SSC History of pulmonary thromboembolism OSA Gastritis Nicotine abuse |
2 | 28 years | Female | 16 days | Acute liver failure | Celiac trunk ischemia | COVID-19 with ARDS | Coinfection with CandidaR ight heart insufficiency Asthma Obesity (WHO grade III) |
3 | 30 years | Female | 18 days | Septic MOF | Sepsis | Intestinal GvHD |
COVID-19 Coinfection with CMV Toxoplasmosis Dermal GvHD t-MDS (allo-HSCT, ruxolitinib) Ewing sarcoma (chemotherapy) Graves’ disease |
4 | 33 years | Male | 30 days | Hemorrhagic shock | Airway bleeding | COVID-19 | Acute pulmonary thromboembolism |
5 | 45 years | Female | 19 days | Septic MOF | SARS-CoV-2 pneumonia | Viral pneumonia |
Staph. aureus coinfection Mesenterial infarction Arterial hypertension Asthma COPD |
6 | 46 years | Male | 18 days | Cardiogenic shock | SARS-CoV-2 pneumonia | Dilated cardiomyopathy | Chronic left ventricular heart thrombus Anxiety disorder Benzodiazepine abuse |
Abbreviations: cause of death (COD), multiple organ failure (MOF), severe acute respiratory syndrome coronavirus type 2 (SARS CoV-2), coronavirus disease 2019 (COVID-19), cytomegalovirus (CMV), human herpes virus 1 (HHV-1), secondary sclerosing cholangitis (SCC), obstructive sleep apnea (OSA), World Health Organization (WHO), graft-versus-host disease (GvHD), therapy-induced myelodysplastic syndrome (t-MDS), allogeneic hematopoietic stem cell transplantation (allo-HSCT), Staphylococcus (Staph.), chronic obstructive pulmonary disease (COPD).